RESEARCH

For nearly 50 years, there have been few advances that have yielded new treatment options for pancreatic cancer. This is one of the reasons why survival rates have not improved at the same pace as most other cancers.
We are working to change that.

By investing in cutting-edge research projects and working in collaboration with organizations that have the same motivation, we will reach our goals faster and ultimately save more lives.

Psilocybin-Assisted Therapy

Harnessing AI For Early Detection

Past Research Investments

Pancreatic Cancer North America

800 Third Avenue FRNT A #1523
New York, NY
10022

Toll Free: 1-844-274-3640
info@pancreaticcancerna.org

Pancreatic Cancer North America is a 501 (c)(3) non-profit recognized by the IRS. Tax ID #84-5185853. Any contributions to Pancreatic Cancer North America are tax-deductible as permitted by law.

Pancreatic Cancer North America is proud to work in partnership with Pancreatic Cancer Canada.

Research

For nearly 50 years, there have been few advances that have yielded new treatment options for pancreatic cancer. This is one of the reasons why survival rates have not improved at the same pace as most other cancers. We are working to change that.

By investing in cutting-edge research projects and working in collaboration with organizations that have the same motivation, we will reach our goals faster and ultimately save more lives.

Pancreatic Cancer North America

For nearly 50 years, there have been few advances that have yielded new treatment options for pancreatic cancer. This is one of the reasons why survival rates have not improved at the same pace as most other cancers.
We are working to change that.